Literature DB >> 17706880

Somatostatin inhibits the excitability of rat small-diameter trigeminal ganglion neurons that innervate nasal mucosa and project to the upper cervical dorsal horn via activation of somatostatin 2a receptor.

M Takeda1, J Kadoi, M Takahashi, M Nasu, S Matsumoto.   

Abstract

This study investigated whether somatostatin (SST) modulates the excitability of nociceptive trigeminal ganglion (TRG) neurons that innervate the nasal mucosa and project to the upper cervical (C(1)) dorsal horn by using perforated-patch clamping, retrograde-labeling, and immunohistochemistry. Fluorogold (FG) retrograde labeling was used to identify the rat TRG neurons innervating the nasal mucosa, while microbeads (MB) were used to label neurons projected onto the superficial layer of the C(1) dorsal horn. FG-labeled small-diameter TRG neurons exhibited SST(2A) receptor immunoreactivity (19%) and half of these neurons were also labeled with MB. In whole-cell current-clamp mode, most (72%) of the dissociated FG-/MB-labeled TRG neurons were hyperpolarized by application of SST. The hyperpolarization was evoked by SST in a concentration-dependent manner (0.1-10 microM) and the responses were associated with a decrease in the cell input resistance. The minimum concentration to elicit a significant hyperpolarization was 1 microM. The repetitive firings during a depolarizing pulse were significantly reduced by SST (1 microM) application. The hyperpolarization and decreased firing evoked by SST were both blocked by the SST(2) receptor antagonist, CYN154806 (1 microM). Under voltage-clamp conditions, SST (1 microM) significantly increased the voltage-gated K(+) transient (I(A)) and sustained (I(K)) currents and these increases were abolished by coapplication of CYN154806 (1 microM). In the presence of both 4-aminopyridine (6 mM) and tetraethylammonium (10 mM), no significant changes in the membrane potential in response to SST application were found. These results suggest that modulation of trigeminal nociceptive transmission in the C(1) dorsal horn by activation of SST(2A) receptors occurs at the level of small-diameter TRG cell bodies and/or their afferent terminals, and that this may be related to regulation of protective upper-airway reflexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706880     DOI: 10.1016/j.neuroscience.2007.06.048

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

Review 1.  Transmission of pruriceptive signals.

Authors:  Santosh K Mishra; Mark A Hoon
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Somatostatin inhibits tooth-pulp-evoked rat cervical dorsal horn neuronal activity.

Authors:  M Takahashi; M Takeda; S Matsumoto
Journal:  Exp Brain Res       Date:  2008-01-09       Impact factor: 1.972

3.  Brain-derived neurotrophic factor enhances the excitability of small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone following masseter muscle inflammation.

Authors:  Mamoru Takeda; Masayuki Takahashi; Junichi Kitagawa; Takuya Kanazawa; Masanori Nasu; Shigeji Matsumoto
Journal:  Mol Pain       Date:  2013-09-30       Impact factor: 3.395

Review 4.  Neuropeptides and ATP signaling in the trigeminal ganglion.

Authors:  Tetsuya Goto; Haruki Iwai; Eriko Kuramoto; Atsushi Yamanaka
Journal:  Jpn Dent Sci Rev       Date:  2017-03-15

5.  Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.

Authors:  Tie-Jun Sten Shi; Qiong Xiang; Ming-Dong Zhang; Swapnali Barde; Ylva Kai-Larsen; Kaj Fried; Anna Josephson; Laura Glück; Sergey M Deyev; Andrei V Zvyagin; Stefan Schulz; Tomas Hökfelt
Journal:  Mol Pain       Date:  2014-02-13       Impact factor: 3.395

6.  The Neuropeptide Cortistatin Alleviates Neuropathic Pain in Experimental Models of Peripheral Nerve Injury.

Authors:  Clara P Falo; Raquel Benitez; Marta Caro; Maria Morell; Irene Forte-Lago; Pedro Hernandez-Cortes; Clara Sanchez-Gonzalez; Francisco O'Valle; Mario Delgado; Elena Gonzalez-Rey
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.